, 0Á97 (0Á76?1Á24)

, 0Á83 (0Á64?1Á08) 1Á02 (0Á87?1Á19) 0Á84

, Adults, issue.1, 1934.

, <16 years) (n 1 = 670, Children

, Pregnant, pp.13-54

, Intensive care unit (ICU) patients (all ages) Adults (?16 years) (n 1 = 583

, Children, issue.1, pp.2-447

N. Early, ?2 days) versus later NAI (>2 days) Laboratory and clinically confirmed (all ages) (n 1 = 5058, p.925

, 0Á46?0Á57)*** Laboratory-confirmed cases (all ages), p.667

, patients (all ages) Adults (?16 years) (n 1 = 1846, Adults (?16 years) (n 1 = 4189; n 2 = 7549)<16 years) (n 1 = 864; n 2 = 3295) 0Á43 (0Á29?0Á62)*** 0Á47 (0Á32?0Á71))*** Children (<16 years), pp.13-54

, Later (>2 days) versus no NAI treatment Laboratory and clinically confirmed (all ages) (n 1 = 3991, p.8251

, 1Á34?1Á84)*** Laboratory-confirmed cases (all ages)

, 1 = 3263, Adults, pp.1-28

, ICU patients Adults (?16 years) (n 1 = 1511; n 2 = 2249) 2Á35 (1Á31?4Á23)** 1Á55 (0Á83?2Á89) 1Á68 (1Á15?2Á46)** 1Á47, pp.1-1

, 1Á39?4Á96)** NAI anytime versus no NAI treatment Laboratory and clinically confirmed (all ages) (n 1 = 7975, 1Á08?1Á38)** Laboratory-confirmed cases (all ages))*** 1Á29 (1Á06?1Á57)* 1Á58 (1Á41?1Á78)*** 1Á19 (1Á05?1Á35)**, pp.164-165

, Adults (?16 years) (n 1 = 5964; n 2 = 13 247) 1Á53 (1Á24?1Á91)*** 1Á30 (1Á03?1Á63)* 1Á63 (1Á40?1Á89)*** 1Á24 (1Á06?1Á46)** Children (<16 years) (n 1 = 2005; n 2 = 6760) 1Á38 (1Á00?1Á90)* 1Á30, pp.0-92

, Pregnant, pp.13-54

, ICU patients (all ages) Adults (?16 years) (n 1 = 2721; n 2 = 4071) 2Á02 (1Á30?3Á14)** 1Á57 (1Á00?2Á48)* 1Á58 (1Á14?2Á18)** 1Á38, pp.1-1

, <16 years) (n 1 = 970; n 2 = 1579) 1Á45 (0Á89?2Á38) 1Á39 (0Á85?2Á29) 1Á76 (1Á22?2Á53)** 1Á59, pp.1-10

, n 1 = total number of patients included in IRP analysis; n 2 = total number of patients included in 'any pneumonia' analysis

*. P. 0á001, ?Influenza-related pneumonia and physician-diagnosed pneumonia. ? ?Adjusted for treatment propensity quintiles

. Muthuri,

N. Lee, P. Chan, and G. Lui, Complications and Outcomes of Pandemic 2009 Influenza A (H1N1) Virus Infection in Hospitalized Adults: How Do They Differ From Those in Seasonal Influenza?, Journal of Infectious Diseases, vol.202, issue.6, pp.1739-1747, 2011.
DOI : 10.1086/655904

R. Perez-padilla, D. De-la-rosa-zamboni, and S. Ponce-de-leon, Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico, New England Journal of Medicine, vol.361, issue.7, pp.680-689, 2009.
DOI : 10.1056/NEJMoa0904252

S. Reyes, B. Montull, and R. Martinez, Risk factors of A/H1N1 etiology in pneumonia and its impact on mortality, Respiratory Medicine, vol.105, issue.9, pp.1404-1411, 2011.
DOI : 10.1016/j.rmed.2011.04.011

J. Louie, M. Acosta, and K. Winter, Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California, JAMA, vol.302, issue.17, pp.1896-1902, 2009.
DOI : 10.1001/jama.2009.1583
URL : http://jama.jamanetwork.com/data/journals/jama/4486/joc90126_1896_1902.pdf

J. Nguyen-van-tam, P. Openshaw, and H. A. , Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009), Thorax, vol.65, issue.7, pp.645-651, 2009.
DOI : 10.1136/thx.2010.135210
URL : http://europepmc.org/articles/pmc2921287?pdf=render

, Influenza antiviral medications: summary for clinicians, Centers for Disease Control and Prevention, 2014.

, Clinical management of human infection with pandemic (H1N1) 2009: Revised guidance, World Health Organization, 2009.

L. Kaiser, C. Wat, T. Mills, P. Mahoney, P. Ward et al., Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and Hospitalizations, Archives of Internal Medicine, vol.163, issue.14, pp.1667-1672, 2003.
DOI : 10.1001/archinte.163.14.1667

J. Hsu, N. Santesso, and R. Mustafa, Antivirals for Treatment of Influenza, Annals of Internal Medicine, vol.156, issue.7, pp.512-524, 2012.
DOI : 10.7326/0003-4819-156-7-201204030-00411

T. Jefferson, M. Jones, and P. Doshi, Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children, Cochrane Database Syst Rev, vol.1, p.8965, 2012.

T. Jefferson, M. Jones, and P. Doshi, Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children, Cochrane Database Syst Rev, vol.4, p.8965, 2014.

J. Dobson, R. Whitley, S. Pocock, and A. Monto, Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials, The Lancet, vol.385, issue.9979, pp.1729-1737, 2015.
DOI : 10.1016/S0140-6736(14)62449-1

V. Hiba, M. Chowers, I. Levi-vinograd, B. Rubinovitch, L. Leibovici et al., Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study, Journal of Antimicrobial Chemotherapy, vol.31, issue.5, pp.1150-1155, 2011.
DOI : 10.2165/0002018-200831120-00006

A. Nakai, H. Minakami, and N. Unno, Characteristics of pregnant Japanese women who required hospitalization for treatment of NAIs for influenza-related pneumonia

, The Authors Influenza and Other Respiratory Viruses Published by 203 pandemic (H1N1) 2009?low mortality rate may be due to early antiviral use, J Infect, vol.62, pp.232-233, 2011.

D. Viasus, J. Pano-pardo, and J. Pachon, Pneumonia Complicating Pandemic (H1N1) 2009, Medicine, vol.90, issue.5, pp.328-336, 2011.
DOI : 10.1097/MD.0b013e31822e67a7

H. Iglesias, A. Kudo, K. Manabe, and T. , Reducing Occurrence and Severity of Pneumonia Due to Pandemic H1N1 2009 by Early Oseltamivir Administration: A Retrospective Study in Mexico, PLoS ONE, vol.50, issue.7, p.21838, 2011.
DOI : 10.1371/journal.pone.0021838.t005

S. Muthuri, P. Myles, S. Venkatesan, J. Leonardi-bee, and J. Nguyen-van-tam, Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009-2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients, Journal of Infectious Diseases, vol.67, issue.8, pp.553-563, 2013.
DOI : 10.1136/thoraxjnl-2011-200266

S. Muthuri, P. Myles, J. Leonardi-bee, S. Venkatesan, and J. Nguyen-van-tam, on behalf of the PRIDE Research Collaboration. Post-Pandemic Review of Anti-Influenza Drug Effectiveness, Pride Study): An Investigation of the Impact of Neuraminidase Inhibitor Antiviral Use on Pneumonia and Length of Hospital Stay in Hospitalized Influenza A (H1N1)pdm09 Patients [Abstract]. Riga: The European Scientific Workshop on Influenza (ESWI), 2014.

S. Muthuri, S. Venkatesan, and P. Myles, Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data, The Lancet Respiratory Medicine, vol.2, issue.5, pp.395-404, 2014.
DOI : 10.1016/S2213-2600(14)70041-4
URL : https://hal.archives-ouvertes.fr/hal-01274568

P. Myles, J. Leonardi-bee, J. Van-tam, S. Muthuri, and S. Venkatesan, A systematic review of the impact of neuraminidase inhibitor antiviral use on outcomes of public health importance during the, ?ID=CRD42011001 273#.UvDWqFFNKW8, 2009.

, 21

T. Franquet, Imaging of pneumonia: trends and algorithms, European Respiratory Journal, vol.18, issue.1, pp.196-208, 2001.
DOI : 10.1183/09031936.01.00213501

T. Bewick, P. Myles, and S. Greenwood, Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults, Thorax, vol.66, issue.3, pp.247-252, 2011.
DOI : 10.1136/thx.2010.151522
URL : https://thorax.bmj.com/content/66/3/247.full.pdf

N. Lee, K. Choi, and P. Chan, Outcomes of adults hospitalised with severe influenza, Thorax, vol.65, issue.6, pp.510-515, 2010.
DOI : 10.1136/thx.2009.130799
URL : https://thorax.bmj.com/content/65/6/510.full.pdf

J. Louie, S. Yang, and M. Acosta, Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1)pdm09, Clinical Infectious Diseases, vol.201, issue.11, pp.1198-1204, 2012.
DOI : 10.1086/652498
URL : https://academic.oup.com/cid/article-pdf/55/9/1198/1196753/cis636.pdf

A. Mcgeer, K. Green, and A. Plevneshi, Antiviral Therapy and Outcomes of Influenza Requiring Hospitalization in Ontario, Canada, Clinical Infectious Diseases, vol.43, issue.4, pp.1568-1575, 2007.
DOI : 10.1086/505868

W. Adisasmito, P. Chan, and N. Lee, Effectiveness of Antiviral Treatment in Human Influenza A(H5N1) Infections: Analysis of a Global Patient Registry, The Journal of Infectious Diseases, vol.202, issue.8, pp.1154-1160, 2010.
DOI : 10.1086/656316

N. Lee, C. Cockram, P. Chan, D. Hui, K. Choi et al., Antiviral Treatment for Patients Hospitalized with Severe Influenza Infection May Affect Clinical Outcomes, Clinical Infectious Diseases, vol.12, issue.8, pp.1323-1324, 2008.
DOI : 10.1086/520981

N. Lee, P. Chan, and D. Hui, Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza, The Journal of Infectious Diseases, vol.200, issue.4, pp.492-500, 2009.
DOI : 10.1086/600383

C. Kim, W. Lew, and M. Williams, Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site:?? Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza Activity, Journal of the American Chemical Society, vol.119, issue.4, pp.681-690, 1997.
DOI : 10.1021/ja963036t

P. Meindl, G. Bodo, P. Palese, J. Schulman, and H. Tuppy, Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid, Virology, vol.58, issue.2, pp.457-463, 1974.
DOI : 10.1016/0042-6822(74)90080-4

C. Eriksson, D. Graham, T. Uyeki, and A. Randolph, Risk factors for mechanical ventilation in U.S. children hospitalized with seasonal influenza and 2009 pandemic influenza A*, Pediatric Critical Care Medicine, vol.13, issue.6, pp.625-631, 2012.
DOI : 10.1097/PCC.0b013e318260114e